Allworth Financial LP Takes $2.71 Million Position in Agilent Technologies, Inc. $A

Allworth Financial LP purchased a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 20,420 shares of the medical research company's stock, valued at approximately $2,712,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of A. Brighton Jones LLC increased its position in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after buying an additional 270 shares during the period. Jones Financial Companies Lllp raised its stake in Agilent Technologies by 15.9% during the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock worth $602,000 after acquiring an additional 769 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock valued at $70,000 after acquiring an additional 212 shares during the last quarter. Acadian Asset Management LLC increased its stake in shares of Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock valued at $625,000 after buying an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new stake in shares of Agilent Technologies during the second quarter worth $273,000.

Agilent Technologies Stock Performance

Shares of A opened at $159.25 on Friday. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market cap of $44.98 billion, a P/E ratio of 31.98, a P/E/G ratio of 2.77 and a beta of 1.25. The business's 50 day moving average price is $137.57 and its 200-day moving average price is $126.23. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.51.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.08. The firm had revenue of $1.83 billion for the quarter, compared to analysts' expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The company's quarterly revenue was up 10.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A has been the topic of a number of research analyst reports. Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Sunday, August 2nd. Royal Bank Of Canada started coverage on Agilent Technologies in a research note on Wednesday, May 27th. They set an "outperform" rating and a $153.00 price objective on the stock. Sanford C. Bernstein started coverage on Agilent Technologies in a report on Friday, June 26th. They set an "outperform" rating and a $155.00 price target on the stock. Robert W. Baird upped their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research note on Tuesday, May 26th. Finally, Wells Fargo & Company decreased their target price on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research report on Thursday, May 28th. Two analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $160.24.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source